Madrigal Pharmaceuticals Inc (MDGL) Price Prediction & ForecastMDGLMadrigal Pharmaceuticals Inc

Alphio's MDGL stock price prediction model matches the current Madrigal Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $451.92 (+1.08%). The 1-week path is $457.33 (+2.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Madrigal Pharmaceuticals is a good buy right now due to its current price of $449.74, which is significantly lower than analyst price targets, with Goldman Sachs at $704 and Citi at $725. The company has shown strong sales growth with Rezdiffra achieving $364.3 million in Q2, a 71% year-over-year increase, indicating robust market demand. However, the main risk is the high forward P/E ratio of 78.125, suggesting that the stock is priced for significant future growth, which may not materialize if market conditions change.

Madrigal Pharmaceuticals Inc (MDGL) last closed at $447.09, losing -0.59%. These facts feed the 1-day and 1-week MDGL price prediction above.